PACS Group is the top performing healthcare facilities' stock YTD
Seeking Alpha News (Mon, 22-Dec 3:38 PM ET)
Ryder System, Inc. Elects Tammy Romo to Its Board of Directors
Business Wire (Fri, 19-Dec 6:55 AM ET)
Business Wire (Mon, 3-Nov 5:25 PM ET)
Business Wire (Mon, 3-Nov 8:51 AM ET)
Tenet Healthcare Lifts 2025 Outlook as Adjusted Earnings and Cash Flow Show Strong Growth
Market Chameleon (Tue, 28-Oct 3:47 AM ET)
Tenet Reports Strong Third Quarter 2025 Results; Raises 2025 Financial Outlook
Business Wire (Tue, 28-Oct 6:45 AM ET)
Tenet to Report Its Third Quarter 2025 Results on October 28th
Business Wire (Tue, 30-Sep 9:00 AM ET)
THC Call Spread Trade Totals $445K With 10.7% Gain in One Hour—Are Technicals and Skew Aligned?
Market Chameleon (Wed, 20-Aug 7:09 AM ET)
THC Call Spread Volume Hits $933K—Buyers Target $1.4M Upside Amid Technical Strength
Market Chameleon (Tue, 19-Aug 10:09 AM ET)
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (47 as of December 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Tenet Healthcare trades on the NYSE stock market under the symbol THC.
As of December 26, 2025, THC stock price climbed to $200.13 with 153,606 million shares trading.
THC has a beta of 1.04, meaning it tends to be more sensitive to market movements. THC has a correlation of 0.21 to the broad based SPY ETF.
THC has a market cap of $17.59 billion. This is considered a Large Cap stock.
Last quarter Tenet Healthcare reported $5 billion in Revenue and $3.70 earnings per share. This beat revenue expectation by $44 million and exceeded earnings estimates by $.36.
In the last 3 years, THC traded as high as $222.82 and as low as $46.53.
The top ETF exchange traded funds that THC belongs to (by Net Assets): VTI, IJH, VB, VBR, VXF.
THC has outperformed the market in the last year with a price return of +54.3% while the SPY ETF gained +15.9%. However, in the short term, THC had mixed performance relative to the market. It has underperformed in the last 3 months, returning +1.8% vs +4.6% return in SPY. But in the last 2 weeks, THC shares have fared better than the market returning +1.3% compared to SPY +0.6%.
THC support price is $194.64 and resistance is $200.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that THC shares will trade within this expected range on the day.